These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 555789)

  • 1. [The role of enteric bacteria in childhood urinary tract infections and their in vitro response to antimicrobial agents].
    Günalp A
    Mikrobiyol Bul; 1979 Jan; 13(1):13-25. PubMed ID: 555789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiologies of the urinary tract infections in a Yemeni City.
    Nasher MA; Nasher TM; Gunaid AA
    Saudi Med J; 2001 Jul; 22(7):599-602. PubMed ID: 11479641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriology of community acquired urinary tract infection. Analysis of 1048 cases.
    Vigg A; Jad CY
    J Assoc Physicians India; 1991 Aug; 39(8):601-3. PubMed ID: 1814873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of bacteria causing urinary tract infections towards terizidon (author's transl)].
    Wewalka G; Rotter M; Fischer A
    Wien Klin Wochenschr; 1976 May; 88(11):355-60. PubMed ID: 826024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Causative agents of urinary tract infections and sensitivity to antibiotics].
    Ayhan N; Başbuğ N; Oztürk S
    Mikrobiyol Bul; 1988; 22(3):215-21. PubMed ID: 3252113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and sensitivity to antibiotics of Enterobacteriaceae isolated from urinary cultures in some microbiology laboratories of a city in west Greece.
    Papapetropoulou M; Pagonopoulou O; Kouskouni E
    Pathol Biol (Paris); 1997 Nov; 45(9):716-20. PubMed ID: 9538469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer carbapenems for urinary tract infections.
    Matsumoto T; Muratani T
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of a new and rapid antibiotic sensitivity method testing for Enterobacteriaceae responsible for urinary infections].
    Laudat P; Crouzier C
    Pathol Biol (Paris); 1997 May; 45(5):389-93. PubMed ID: 9296090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
    Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
    Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with ciprofloxacin in vitro and in vivo.
    Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
    Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children].
    Szozda G; Nowakowska K
    Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial drug resistance of gram-negative agents causing urinary infections in female outpatients in Russia: results of multicenter study].
    Strachunskiĭ LS; Sekhin SV; Abramova ER; Reshed'ko GK; Petrochenkova NA; Eĭdel'shteĭn IA; Suvorov MM; Krechikova OI; Il'ina VN; Petrova TA; Gugutsidze EN; Furletova NM
    Ter Arkh; 2000; 72(6):30-5. PubMed ID: 10900645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology and antimicrobial susceptibility pattern of bacterial pathogens from urinary tract infection.
    Khatri B; Basnyat S; Karki A; Poudel A; Shrestha B
    Nepal Med Coll J; 2012 Jun; 14(2):129-32. PubMed ID: 23671963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.